Vol 14, No 2 (2012)
- Year: 2012
 - Published: 15.06.2012
 - Articles: 16
 - URL: https://modernonco.orscience.ru/1815-1434/issue/view/1673
 
Articles
V Moskve sostoyalos' obsuzhdenie proekta Rossiyskikh klinicheskikh rekomendatsiy po diagnostike i lecheniyu zlokachestvennykh limfoproliferativnykh zabolevaniy, osnovannykh na printsipakh dokazatel'noy meditsiny i mnenii ekspertov
Journal of Modern Oncology. 2012;14(2):4-
		
				
					4-
				
						
			
				
				
			
		Issledovanie III fazy: znachitel'noe uvelichenie prodolzhitel'nosti zhizni u patsientov s naibolee rasprostranennym tipom nemelkokletochnogo raka legkogo, poluchavshikh prodolzhennuyu podderzhivayushchuyu terapiyu na osnove preparata Alimta
Journal of Modern Oncology. 2012;14(2):5-
		
				
					5-
				
						
			
				
				
			
		Dzhevtana® (kabazitaksel) - novyy preparat dlya lecheniya metastaticheskogo gormonorezistentnogo raka predstatel'noy zhelezy zaregistrirovan v Rossii
Journal of Modern Oncology. 2012;14(2):6-7
		
				
					6-7
				
						
			
				
				
			
		Novye vozmozhnosti targetnoy terapii v onkodermatologii
Journal of Modern Oncology. 2012;14(2):7-
		
				
					7-
				
						
			
				
				
			
		Rakovye registry: vchera, segodnya, zavtra. Chast' 2
Journal of Modern Oncology. 2012;14(2):8-9
		
				
					8-9
				
						
			
				
				
			
		Bendamustin v terapii nekhodzhkinskikh limfom
Journal of Modern Oncology. 2012;14(2):10-12
		
				
					10-12
				
						
			
				
				
			
		Cubpopulyatsionnyy sostav i tsitokinsekretornaya funktsiya kletok produkta separatsii u bol'nykh limfomami
Journal of Modern Oncology. 2012;14(2):14-19
		
				
					14-19
				
						
			
				
				
			
		Kliniko-ekonomicheskiy analiz primeneniya everolimusa (Afinitor) pri metastaticheskom rake pochki s uchetom kolichestva dobavlennykh let zhizni s popravkoy na kachestvo zhizni
Journal of Modern Oncology. 2012;14(2):20-24
		
				
					20-24
				
						
			
				
				
			
		Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami
Journal of Modern Oncology. 2012;14(2):25-28
		
				
					25-28
				
						
			
				
				
			
		Tretichnyy pokazatel' Glisona kak faktor prognoza retsidiva raka predstatel'noy zhelezy
Journal of Modern Oncology. 2012;14(2):28-31
		
				
					28-31
				
						
			
				
				
			
		Antiangiogennaya terapiya v lechenii glioblastomy: obzor i sobstvennye klinicheskie dannye
Journal of Modern Oncology. 2012;14(2):31-37
		
				
					31-37
				
						
			
				
				
			
		Rezul'taty khirurgicheskogo lecheniya metastaticheskogo kolorektal'nogo raka posle provedeniya lekarstvennoy terapii s dobavleniem bevatsizumaba
Journal of Modern Oncology. 2012;14(2):38-41
		
				
					38-41
				
						
			
				
				
			
		Opyt uspeshnogo lecheniya HER2-pozitivnogo metastaticheskogo raka zheludka
Journal of Modern Oncology. 2012;14(2):41-45
		
				
					41-45
				
						
			
				
				
			
		Korrektsiya anemii u bol'nykh mnozhestvennoy mielomoy s pomoshch'yu eritropoez-stimuliruyushchikh preparatov
Journal of Modern Oncology. 2012;14(2):45-50
		
				
					45-50
				
						
			
				
				
			
		Khirurgicheskoe lechenie mestnorasprostranennogo i retsidivnogo orofaringeal'nogo raka v plane kombinirovannogo i kompleksnogo podkhoda
Journal of Modern Oncology. 2012;14(2):50-53
		
				
					50-53
				
						
			
				
				
			
		K voprosu o real'nykh vozmozhnostyakh luchevoy terapii mestnorasprostranennykh rakov kozhi chelyustno-litsevoy oblasti
Journal of Modern Oncology. 2012;14(2):54-64
		
				
					54-64
				
						
			
				
				
			
		
					
						
						
				


